Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.
about
Molecular mechanisms and treatment of bone metastasis.Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.Estrogen prevents the reduction in fractional calcium absorption due to energy restriction in mature rats.Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical studySynthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.Update on estrogens and the skeletonAdjuvant Endocrine Therapy in Early Postmenopausal Breast CancerEffects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women.Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activitiesTissue physiology and pathology of aromatase.Update on medications with adverse skeletal effectsIndependent and combined effect of nutrition and exercise on bone mass development.Distributional variations in trabecular architecture of the mandibular bone: an in vivo micro-CT analysis in rats.The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?Letrozole in the extended adjuvant setting: MA.17Sequencing of aromatase inhibitors.The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosisFulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer.Aromatase inhibitors and bone loss.Effects of adjuvant aromatase inhibitor therapy on lipid profiles.Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.Differences in trabecular bone of leptin-deficient ob/ob mice in response to biomechanical loadingSuppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition.Estradiol rates of change in relation to the final menstrual period in a population-based cohort of womenOral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.Breast cancer in young women and its impact on reproductive functionAromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: a Peripheral Quantitative Computed Tomography (pQCT) study.Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.Emerging drugs for the management of cancer treatment induced bone loss.Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.Managing bone health with zoledronic acid: a review of randomized clinical study results.Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.Effects of letrozole on bone biomarkers and femur fracture in female rats.Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.
P2860
Q30445717-1A39CEBB-B5DF-47D6-AC0E-825D44ACF92FQ30738576-973EA2ED-BA99-4342-9DBC-1BCE91A284AFQ33554161-883CE3DF-7436-4C02-9443-8DB2A7F95FC8Q33649834-5E4C8EC6-C549-499A-9816-A626E6A5B3CFQ33705490-1960AF4D-3297-4329-9CA7-919B7A5D21B5Q34031994-A36B33B5-AAA8-47FB-888A-578481B70D63Q34096283-8192C906-6F62-498B-A364-3A435C4A23D1Q34262504-9523E683-E7F5-4568-BB45-3E2855D78AB7Q34466243-4973C867-D477-4BEE-845D-41A384C1539AQ34633879-168219D2-B505-44CB-8D6B-31725BB75CB7Q34748485-37C1EFE3-172E-4B4A-ADCB-5C80F66ED49AQ34817711-B082CBE3-43E7-4630-8C1A-D79D167D2AA9Q35018865-0D70D8D0-3421-4363-91B8-DA603AB527CEQ35229894-453483AA-7A39-4206-98CA-546C4703086BQ36026553-1F60D116-FA25-4AB6-ADA8-853B5C5F92D8Q36229445-EE392490-B3B6-4F97-BCD0-517DA4D516A9Q36553435-81C35579-B992-4B28-9375-9FA1638D86CEQ36567154-769DA8E2-B117-43B9-B8E4-62FFA0362C21Q36598622-1964C05B-9130-488C-A51B-EB5593821DECQ36668265-4D8491BC-148B-4D27-9596-658C28F29449Q36695888-376AE1D2-CA4C-4233-BAD0-CAFF71479CB4Q36703918-6D253399-10AB-4927-B0BB-24590150B3ACQ36727188-D8DD9FF4-5FA3-4B01-BFBA-C0A3FAFBD7AEQ36802784-762B9844-02C7-4AE9-AE3C-DC603761A5C3Q36964836-B7B68858-08D4-44EB-BE8A-C50F53E28572Q37146402-9697E5A4-D427-4226-B9FC-75FB27F27496Q37153908-15A7A2E2-4DA1-4849-B2D2-6A7B6B1C44DEQ37193002-D25FCF50-7612-40C7-8616-1A5134DE71BAQ37407699-65104FBD-626F-467A-8B70-102C07EA8F3FQ37449530-E27DFC87-3FE7-416D-9F8F-203334336E5CQ37665513-08CFF37F-DD31-487E-8A71-8D31C8802321Q37727235-E5F1F678-5B61-415D-B9E4-077FDBF3B07AQ37805634-24949AAB-09F1-4371-B617-239B5B472588Q37823605-467BA145-8F02-45BE-97ED-68781800B1EDQ38739248-CEC5F2D7-A9F9-448E-8B97-55BA752403C8Q42666503-862C899B-6F18-4015-8065-55F5917EEC82Q43179083-67616E38-2AF0-4886-BA48-9A9E82C17D08Q45197592-5DD89317-51F2-429E-A0A2-BB761300BE2DQ46938210-6C0CF9B0-737E-4BDC-8EF3-9927870FC048Q48226422-10B62160-85E7-4C64-9960-AAB2BE4878D4
P2860
Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Role of low levels of endogeno ...... in late postmenopausal women.
@en
Role of low levels of endogeno ...... in late postmenopausal women.
@nl
type
label
Role of low levels of endogeno ...... in late postmenopausal women.
@en
Role of low levels of endogeno ...... in late postmenopausal women.
@nl
prefLabel
Role of low levels of endogeno ...... in late postmenopausal women.
@en
Role of low levels of endogeno ...... in late postmenopausal women.
@nl
P2093
P1476
Role of low levels of endogeno ...... in late postmenopausal women.
@en
P2093
B Lawrence Riggs
Hassan M Heshmati
L Joseph Melton
Simon P Robins
Sundeep Khosla
W Michael O'Fallon
P304
P356
10.1359/JBMR.2002.17.1.172
P577
2002-01-01T00:00:00Z